Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Curran · SciRah

Researcher profile · Semantic Scholar

K. Curran

Share profile

K. Curran — researcher profile on SciRah

h-index: 42
Works: 166
Citations: 16K

Most-cited papers

ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
Daniel W. Lee, B. Santomasso, F. Locke, A. Ghobadi +18 more
2018Biology of Blood and Marrow Transplantation3,314 citations Open access
Semantic Scholar
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, I. Rivière, M. Gonen, Xiu-Yan Wang +11 more
2018New England Journal of Medicine2,194 citations Open access
Semantic Scholar
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.
M. Pasquini, Zhen-Huan Hu, K. Curran, T. Laetsch +27 more
2020Blood Advances390 citations Open access
Semantic Scholar
CD40 Ligand-Modified Chimeric Antigen Receptor (CAR) T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
Nicholas F. Kuhn, Terence J. Purdon, Dayenne G. van Leeuwen, Andrea V. Lopez +3 more
2019Cancer Cell222 citations Open access
Semantic Scholar
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant.
S. Prockop, E. Doubrovina, Stephanie D. Suser, G. Heller +29 more
2020Journal of Clinical Investigation197 citations Open access
Semantic Scholar
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report
Liora M. Schultz, C. Baggott, Snehit Prabhu, Holly L. Pacenta +29 more
2021Journal of Clinical Oncology194 citations Open access
Semantic Scholar
Toxicity and Response following CD19-specific CAR T cells in pediatric/young adult relapsed/refractory B-ALL.
K. Curran, Steven P. Margossian, N. Kernan, L. Silverman +22 more
2019Blood189 citations Open access
Semantic Scholar
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.
Katherine L. Lee, C. Ambler, David R. Anderson, B. Boscoe +45 more
2017Journal of Medicinal Chemistry140 citations Open access
Semantic Scholar
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy
Vanessa A. Fabrizio, J. Boelens, A. Mauguen, C. Baggott +28 more
2021Blood Advances95 citations Open access
Semantic Scholar
Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial
S. Mailankody, Arnab Ghosh, M. Staehr, Terence J. Purdon +33 more
2018Blood89 citations Open access
Semantic Scholar
Building a CAR Garage: Preparing for the delivery of commercial CAR T products at Memorial Sloan Kettering Cancer Center.
Karlo Perica, K. Curran, R. Brentjens, S. Giralt
2018Biology of Blood and Marrow Transplantation84 citations Open access
Semantic Scholar
CD19 CAR T Cells Following Autologous Transplantation in Poor Risk Relapsed and Refractory B cell non-Hodgkin Lymphoma.
C. Sauter, B. Senechal, I. Rivière, A. Ni +17 more
2019Blood76 citations Open access
Semantic Scholar
Interventions and Outcomes of Adult Patients with B-ALL Progressing After CD19 Chimeric Antigen Receptor T Cell Therapy.
K. Wudhikarn, J. Flynn, I. Rivière, Mithat Gonen +12 more
2021Blood74 citations Open access
Semantic Scholar
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report
Vanessa A. Fabrizio, C. Phillips, Adam Lane, C. Baggott +27 more
2021Blood Advances67 citations Open access
Semantic Scholar
Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells
Haneen Shalabi, Juliane Gust, A. Taraseviciute, P. Wolters +17 more
2021Nature Reviews Clinical Oncology64 citations Open access
Semantic Scholar
CD4+ T-cell reconstitution predicts Survival Outcomes after acute Graft-versus-Host-Disease; a dual center validation.
C. D. de Koning, S. Prockop, I. M. A. A. Van Roessel, N. Kernan +18 more
2020Blood63 citations Open access
Semantic Scholar
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia
Liora M. Schultz, Anne A. Eaton, C. Baggott, J. Rossoff +27 more
2022Journal of Clinical Oncology57 citations Open access
Semantic Scholar
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
A. Moskop, L. Pommert, C. Baggott, Snehit Prabhu +26 more
2021Blood Advances54 citations Open access
Semantic Scholar
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
S. Prockop, A. Hasan, E. Doubrovina, P. Dahi +25 more
2023Journal of Clinical Investigation51 citations Open access
Semantic Scholar
Early CD4+ T cell reconstitution as Predictor for Outcomes after Allogenic Hematopoietic Cell Transplantation
I. M. A. A. Van Roessel, S. Prockop, Elizabeth Klein, F. Boulad +8 more
2020Cytotherapy49 citations Open access
Semantic Scholar
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
H. Stefanski, Anne A. Eaton, C. Baggott, J. Rossoff +26 more
2022Blood Advances46 citations Open access
Semantic Scholar
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia
M. B. Geyer, S. DeWolf, Xiaoli Mi, Kenyon Weis +27 more
2025Blood42 citations Open access
Semantic Scholar
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry
S. Grupp, Zhen-Huan Hu, Yiyun Zhang, A. Keating +17 more
2019Blood40 citations Open access
Semantic Scholar
Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC)
Liora M. Schultz, C. Baggott, Snehit Prabhu, Holly L. Pacenta +24 more
202039 citations
Semantic Scholar
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Sanam Shahid, Kavitha Ramaswamy, J. Flynn, A. Mauguen +9 more
2021Transplantation and Cellular Therapy38 citations Open access
Semantic Scholar
Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
Xiu-Yan Wang, Oriana Bórquez-Ojeda, J. Stefanski, Fang Du +21 more
2021Molecular Therapy: Methods & Clinical Development37 citations Open access
Semantic Scholar
Impact of Bridging Chemotherapy on Clinical Outcome of CD19 CAR T Therapy in Adult Acute Lymphoblastic Leukemia
Karlo Perica, J. Flynn, K. Curran, Isabelle Rivere +10 more
2021Leukemia33 citations Open access
Semantic Scholar
Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
Monica S. Nair, Sara K. Silbert, K. Rejeski, Karilynn A Wilson +12 more
2024Blood32 citations Open access
Semantic Scholar
Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation
M. Lakkaraja, M. Scordo, A. Mauguen, C. Cho +22 more
2021Blood Advances32 citations Open access
Semantic Scholar
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
K. Cornetta, Lisa Duffy, S. Feldman, C. Mackall +15 more
2018Molecular Therapy: Methods & Clinical Development30 citations Open access
Semantic Scholar
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
K. McNerney, Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin +29 more
2023Blood Advances28 citations Open access
Semantic Scholar
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
Sanam Shahid, S. Prockop, Georgia C Flynn, A. Mauguen +20 more
2025Blood Advances26 citations Open access
Semantic Scholar
Low Toxicity and Favorable Overall Survival in Relapsed/Refractory B-ALL following CAR T cells and CD34-selected T Cell Depleted Allogeneic Hematopoietic Cell Transplant.
Vanessa A. Fabrizio, N. Kernan, F. Boulad, M. Cancio +14 more
2020Bone Marrow Transplantation22 citations Open access
Semantic Scholar
Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T Cell Product Manufactured By Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)
N. Jain, P. Chevallier, Hongtao Liu, Gary J. Schiller +15 more
2023Blood21 citations Open access
Semantic Scholar
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
Binni Kunvarjee, Alan Bidgoli, R. Madan, E. Vidal +12 more
2023Journal of Allergy and Clinical Immunology19 citations Open access
Semantic Scholar
Durable Remission Following “Off-the-Shelf” Chimeric Antigen Receptor (CAR) T-Cells in Patients with Relapse/Refractory (R/R) B-Cell Malignancies
K. Curran, C. Sauter, N. Kernan, S. Prockop +9 more
202018 citations Open access
Semantic Scholar
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help
K. Curran, S. Nikiforow, C. Bachier, Y. Hsu +10 more
2023Blood Advances15 citations Open access
Semantic Scholar
Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM
Eric L. Smith, S. Mailankody, Arnab Ghosh, Reed Masakayan +24 more
201715 citations
Semantic Scholar
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
R. Tamari, M. Scordo, Binni Kunvarjee, Anthony J. Proli +22 more
2023Blood Advances14 citations Open access
Semantic Scholar
Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL.
Karlo Perica, J. Flynn, K. Curran, Xiu-Yan Wang +9 more
2019Journal of Clinical Oncology13 citations
Semantic Scholar
CD371-Targeted CAR T-Cells Secreting Interleukin-18 Exhibit Robust Expansion and Disease Clearance in Patients with Refractory Acute Myeloid Leukemia
M. Geyer, S. DeWolf, Xiaoli Mi, B. Shaffer +19 more
2024Blood12 citations
Semantic Scholar
Clinical Variables Associated with Improved Outcomes for Children and Young Adults Treated with CAR T Cells for B-ALL: A Decade of CAR Translation
Regina M. Myers, E. Jacoby, M. Pulsipher, M. Pasquini +5 more
2023Transplantation and Cellular Therapy12 citations Open access
Semantic Scholar
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Valentin V. Barsan, Yimei Li, Snehit Prabhu, C. Baggott +24 more
2023EClinicalMedicine12 citations Open access
Semantic Scholar
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
K. Cornetta, Jing Yao, K. House, Lisa Duffy +27 more
2022Molecular Therapy12 citations Open access
Semantic Scholar
Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia.
J. Rossoff, C. Baggott, Snehit Prabhu, Holly L. Pacenta +24 more
2021Blood12 citations Open access
Semantic Scholar
Durable engraftment and excellent overall survival after CD34-selected peripheral blood stem cell boost in pediatric patients with poor graft function following allogeneic stem cell transplantation
Ellen Fraint, Sana Farooki S, Elizabeth Klein, A. Mauguen +10 more
2022Transplantation and Cellular Therapy10 citations Open access
Semantic Scholar
P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
N. Boissel, P. Chevallier, K. Curran, G. Schiller +15 more
2023HemaSphere8 citations Open access
Semantic Scholar
Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients
Alexandre G. Troullioud Lucas, J. Boelens, S. Prockop, K. Curran +10 more
2023Frontiers in Oncology6 citations Open access
Semantic Scholar
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
Alexandra M Satty, Elizabeth Klein, A. Mauguen, Binni Kunvarjee +13 more
2023Bone Marrow Transplantation6 citations
Semantic Scholar
Early CD4+ T cell reconstitution as Predictor for Outcomes after Allogenic Hematopoietic Cell Transplantation
I. M. A. A. Van Roessel, S. Prockop, Elizabeth Klein, F. Boulad +10 more
20206 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Brentjens×17
Invite
R. Brentjens — researcher profile on SciRah
S. Prockop×14
Invite
S. Prockop — researcher profile on SciRah
N. Kernan×14
Invite
N. Kernan — researcher profile on SciRah
I. Rivière×13
Invite
I. Rivière — researcher profile on SciRah

×13

Invite

Xiu-Yan Wang — researcher profile on SciRah

Invite

T. Laetsch — researcher profile on SciRah

Steven P. Margossian×12

Invite

Steven P. Margossian — researcher profile on SciRah

Invite

J. Boelens — researcher profile on SciRah

Jae H. Park×11

Invite

Jae H. Park — researcher profile on SciRah

Invite

A. Keating — researcher profile on SciRah

Invite

A. Moskop — researcher profile on SciRah

Invite

F. Boulad — researcher profile on SciRah